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The  methylotrophic  yeast  Pichia  pastoris  (Komagataella  phafﬁi)  is  one  of the  most  commonly  used  expres-
sion  systems  for heterologous  protein  production.  However  the recombination  machinery  in  P. pastoris
is less  effective  in  contrast  to  Saccharomyces  cerevisiae,  where  efﬁcient  homologous  recombination  nat-
urally facilitates  genetic  modiﬁcations.  The  lack  of  simple  and  efﬁcient  methods  for gene  disruption  and
speciﬁcally  integrating  cassettes  has remained  a bottleneck  for  strain  engineering  in  P. pastoris.  Therefore
tools and  methods  for  targeted  genome  modiﬁcations  are  of great  interest.
Here  we report  the establishment  of  CRISPR/Cas9  technologies  for P. pastoris  and  demonstrate  targeting
efﬁciencies  approaching  100%.  However  there  appeared  to  be  a narrow  window  of  optimal  conditions
required  for  efﬁcient  CRISPR/Cas9  function  for  this  host.  We  systematically  tested  combinations  of  var-
ious  codon  optimized  DNA  sequences  of  CAS9,  different  gRNA  sequences,  RNA  Polymerase  III and  RNA
Polymerase  II promoters  in  combination  with  ribozymes  for the  expression  of  the  gRNAs  and  RNA  Poly-
merase  II promoters  for the  expression  of  CAS9. Only  6 out of  95  constructs  were  functional  for  efﬁcientultiplexing genome  editing.
We  used  this  optimized  CRISPR/Cas9  system  for  gene  disruption  studies,  to introduce  multiplexed  gene
deletions  and  to  test  the targeted  integration  of  homologous  DNA  cassettes.  This  system  allows  rapid,
marker-less  genome  engineering  in  P. pastoris  enabling  unprecedented  strain  and  metabolic  engineering
applications.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
ontents
1. Introduction  .  . . . .  . . .  .  . . .  .  . . . .  . . .  .  .  . .  .  . . . . . . .  . . . .  . . .  .  . . .  .  . . .  . . . . . .  .  . . . .  . . . . . . . .  . .  . . . .  . . . .  . . .  . . .  . . . .  . . .  .  .  .  . .  . . . . .  . . . . .  . .  . . . . . . .  .  .  .  . . .  .  . . . . . . .  . . . . . .  .  . .  . .  .  140
2. Materials  and  methods  . .  .  . . .  . . . .  . . .  .  . . . .  . . .  .  . . .  . . . .  . . . .  . . . . . . .  . . . .  . . . . . . .  .  . .  .  . . . . . .  .  . . .  . . .  . . .  . . . . . . . . .  . . .  . . . . . . .  . . .  . . . . . . . .  .  .  .  .  . . . .  . . . .  .  .  .  . . .  . . . . . . . .  . 140
2.1.  Chemicals  . .  . .  .  . . . .  . . .  .  . . .  .  . . .  .  . . . .  . . . . . . . . . .  . . . . . . . .  . . .  . . . .  . . . . .  . .  .  . . . . . .  . . .  . . .  . .  .  . . . .  .  . .  . . . . .  . . .  . . .  . . .  . . . .  . . .  .  .  .  . . . .  .  .  .  . .  . . . . . .  . . . .  .  .  . . . .  .  .  .  .  .  140
2.2. Strains  and  constructs  . . . . . . . . . .  . . . .  . . .  .  . . .  . . . .  .  . . .  .  . . . . . .  .  .  . . .  .  .  . . .  . .  . . . . . . .  .  . .  . . . . .  . . . . . .  .  .  . . . . .  .  . . . .  . . .  . . . .  . . .  .  . .  .  . . .  . .  .  .  .  .  . . . . . .  . . . .  .  .  .  .  . . .  141
2.2.1.  Constructs  bearing  RNA  pol  III  promoters  for gRNA  expression  . .  . . .  . .  .  . . . .  .  . .  . .  . . .  . . .  .  . .  . . . . .  . . . . .  . . . . .  . . .  .  .  .  .  . . . . . . .  . . .  . .  .  . .  .  .  . .  . 141
2.2.2.  Constructs  bearing  RNA  pol  II promoters  for  gRNA  expression  . . . .  . . .  .  . . .  . . .  . .  . . .  . . . . .  . . . . .  .  . .  .  . . . .  .  . . . .  . . . . .  .  . .  .  .  .  .  .  . .  . .  .  .  .  . . . . . .  . 141
2.2.3.  P.  pastoris  target  genes  and  multiplexing  . . . . . .  .  .  . . .  . . . . . . . . .  .  . . . . .  . . .  .  .  . . .  . . . .  . . .  . .  .  . . .  .  . . . .  . . . . . . .  .  . . . . . . . . .  .  . . .  . . . . . .  .  . . .  . .  .  . . .  . . .  141
2.2.4.  HR  donor  cassettes  . . .  .  . . .  .  . . .  . . .  . . . .  . . .  .  . . . .  . .  . . . . .  . .  .  .  .  . .  .  . .  . .  . . .  . .  . . . .  . . .  .  . . .  . . .  . . .  .  . . . . .  .  . . . . . . .  .  . . . .  . .  .  . . .  .  . .  .  . .  . . .  .  . . . . . . .  . . .  . .  . 142
2.3.  Transformation  and  screening  . . . . . . . . .  . . . . .  . . .  .  . . .  . . .  . . .  .  . . . . .  . .  . . . . . . .  . . .  . . . . .  .  . . . .  .  . . .  . . . .  .  .  . . . . . .  . . . . . . .  . . .  .  . . . . . .  .  . . .  .  .  .  . . .  . . .  . . .  .  . .  .  . .  .  . . 142
3.  Results  and  discussion  . .  .  . . .  .  . . . .  . . .  . . . .  . . .  . . . . . . . .  .  . . .  . . . . . . .  .  . . . . . .  .  . . . . . .
3.1.  Implementation  of CRISPR/Cas9  in  P. pastoris  .  .  . . .  . . .  .  . . .  . .  . .  .  . .  . . .
3.1.1.  Using  RNA  pol III promoters  for  gRNA expression  did  no
∗ Corresponding author at: Institute for Molecular Biotechnology, Graz University
f  Technology, Petersgasse 14/2, 8010 Graz, Austria.
E-mail address: thomas.vogl@aon.at (T. Vogl).
ttp://dx.doi.org/10.1016/j.jbiotec.2016.03.027
168-1656/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u .  . .  . . . . .  . . . . .  .  . .  .  . . . .  . . .  . . . . .  . . .  . . . . . .  .  . . . . . . .  .  . . . . .  .  . . .  . . . . . .  .  . . .  . .  .  . . . .  .  .  142
 . . .  .  . . .  . .  .  . . . . . . .  .  . . . . .  .  . . . .  . .  .  . . . .  . . .  . . . .  . . .  .  .  .  . . .  .  . . . . .  .  .  . .  . .  .  . . .  . . .  . . .  .  . 142
t  promote  efﬁcient  genome  editing  .  . .  .  . . . .  .  . . .  .  . . . . .  .  . .  .  .  .  .  . . . . . . . .  . . . . 142
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
140 A. Weninger et al. / Journal of Biotechnology 235 (2016) 139–149
3.1.2.  A  combination  of  RNA  pol  II promoters  and  ribozymes  for gRNA  expression
enabled  efﬁcient  CRISPR/Cas9  mediated  genome  editing  . . .  . . . . . . .  .  . . . . . . .  .  .  . . .  . . . . . . . .  . .  . . . .  .  . .  .  . . . .  .  . . .  . . . . . . .  .  . . . . . . . .  .  .  .  .  . . . . . .  . . . .  . .  .  .  145
3.1.3. CAS9  codon  bias  affects  transformation  rate  suggesting  toxic  effects  . . . . .  . .  . . . . .  . . .  . . .  .  . . . .  . . .  . . . .  .  . .  . . .  .  . . .  .  .  . .  .  . . . . . .  .  .  .  .  . .  .  .  .  .  .  145
3.2. A  ribozyme  based  strategy  for  improved  vector  design  . . .  . . .  .  .  . .  . . . .  .  . .  . . .  . . .  . . . . . .  . . . . . . . .  .  . . . . .  .  . . . .  . .  .  .  . . . . . . .  . .  . . . . . . . . . .  .  . .  . .  .  .  . .  .  .  .  . . . . 145
3.3.  Efﬁcient  gene  targeting  and  multiplex  genome  editing  . . . . . .  .  . . . .  .  . .  . . . . .  . . . . . .  . . . .  .  . . . .  .  . .  . . . . . .  .  . . . .  . . .  .  . . .  . . .  .  . . .  . . .  . .  .  . . . . . . . . .  .  .  . . . .  .  .  . .  146
3.4.  CRISPR/Cas9  and  donor  DNA  co-transformations  .  . . . . . . .  . . . . . . .  .  . . . . . .  .  . . . . .  . . .  . . . . .  . . . . . . .  .  . .  . . . .  .  . . . . .  . .  .  . . . . . . . .  .  . . . .  . . . . .  .  . . .  .  .  .  . . .  . . . . . . 147
4. Conclusion  . . .  .  .  . . .  .  .  .  . . .  . . . .  . . . . . . . . . . .  . . . .  . . . .  .  . . .  .  . . . . . . .  . . .  . . . . . . .  . .  . . . . .  .  . . . .  . .  .  . . . . .  .  . . .  . . . .  . . . . . . . .  . .  . . . .  .  . . .  . . .  . . .  .  . . . . . . .  .  .  .  . . . .  . . . . . .  .  .  .  .  . . . .  147
Author’s  contributions  . .  .  . . .  .  . . .  . . .  . . . .  . . .  .  . . .  .  . .  .  .  . .  .  .  . . .  . . . .  . . . . .  .  .  . . .  . . .  . . . .  . . . . . . . . .  . . .  . .  . . .  . . . . .  . . . . .  .  . . .  . . . .  .  . . . .  . . .  . .  . . .  . . . .  .  . .  .  .  .  .  . . . .  . . .  . .  .  . .  147
Acknowledgements  . . .  .  . . .  .  . . . .  . . .  . . . .  . . . .  . . .  . . .  . . .  .  . . .  .  .  . .  .  .  . .  . . . .  . . .  . . . . .  .  . . . .  . .  .  . . . . .  .  . . .  . . . .  . . . . . . . .  . .  .  . . .  . . . .  . . .  . .  .  .  . . . . . . .  .  . .  . . . . . . . . . . .  .  .  .  . .  . .  . 148
Appendix  A.  Supplementary  data  . .  . . . .  . . . . . . .  .  . . . .  . . . .  .  . . . . . . .  . . .  . . . . .  . .  . . . . . . .  . . . . . .  . . .  . . . .  . . .  . . . . .  . . .  . . .  . . . .  . . .  . . .  .  . . . . . . . . .  .  . .  . .  .  . . .  .  . . . . .  .  . . . .  148
. . .  . . .
1
e
e
w
(
‘
m
t
t
N
h
e
o
h
t
o
N
g
a
F
o
g
t
n
h
H
f
r
c
m
p
b
(
S
b
e
p
m
o
M
r
i
(
s
b
e
R
i
s
Austria. D(+)-biotin was obtained from Sigma-Aldrich, Vienna,
Austria. Difco yeast nitrogen base w/o  amino acids, Bacto tryp-
tone and Bacto yeast extract were obtained from Becton Dickinson,
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. Introduction
Pichia pastoris (Komagataella phafﬁi)  is according to a recent lit-
rature survey the most commonly used eukaryotic expression host
ven surpassing Saccharomyces cerevisiae (Bill, 2014). It has been
idely used for protein production in basic and applied research
Ahmad et al., 2014; Gasser et al., 2013). However, in contrast to the
classic’ yeast and model organism S. cerevisiae,  it is considerably
ore difﬁcult to achieve targeted genetic modiﬁcations, because
he homologous recombination (HR) machinery in natural P. pas-
oris strains is less efﬁcient (Higgins and Cregg, 1998; Li et al., 2007;
äätsaari et al., 2012). In contrast, in S. cerevisiae homologous over-
angs of approximately 50 bp are sufﬁcient to achieve targeting
fﬁciencies close to 100%, while in P. pastoris even the addition
f several hundred bp or more than a kbp of homologous over-
angs usually results only in speciﬁc targeting efﬁciency of 0.1%
o 30% (depending on the target locus and the size and the design
f the donor fragment) (Higgins and Cregg, 1998; Li et al., 2007;
äätsaari et al., 2012). Hence so far the introduction of targeted
enetic modiﬁcations has been highly challenging in P. pastoris
nd marker gene recycling (removal) causes additional workload.
or example, in efforts to generate auxotrophic P. pastoris strains,
nly 5 out of 460 tested transformants showed correctly inte-
rated expression cassettes (Nett and Gerngross, 2003). Deleting
he gene coding for the P. pastoris KU70 homolog, a keyplayer in the
on-homologous-endjoining (NHEJ) repair, signiﬁcantly increased
omologous recombination efﬁciencies (Näätsaari et al., 2012).
owever in general NHEJ-defective organisms show lower trans-
ormation rates with linear integration cassettes, reduced growth
ates and an increased sensitivity to radiation and DNA-damaging
onditions (Carvalho et al., 2010; Näätsaari et al., 2012), thereby
eeting demands for improved industrial strain engineering only
artially.
Targeted single and double strand break induced DNA repair can
e used to increase the HR frequency by several orders of magnitude
up to 4000–fold in S. cerevisiae)  (Caldecott, 2008; Rouet et al., 1994;
mih et al., 1995; Storici et al., 2003). Therefore systems introducing
reaks at programmable positions in the genome are of great inter-
st. Recently, CRISPR/Cas9 (clustered regularly interspaced short
alindromic repeats/CRISPR associated protein 9) was  reported to
ediate targeted genome engineering in various pro- and eukary-
tic hosts (DiCarlo et al., 2013; Jacobs et al., 2014; Jinek et al., 2012;
ali et al., 2013; Sander and Joung, 2014) and in principle there is no
eason why this technology should not be applicable in any organ-
sm. It takes advantage of a nuclease, which is guided by a short RNA
guide RNA: gRNA/single guide RNA: sgRNA) to introduce a DNA
trand break at regions complementary to the gRNA sequence. The
reaks are sealed by the recruitment of the cellular repair machin-
ry, allowing the introduction of various genomic modiﬁcations.
eprogramming CRISPR/Cas9 and thereby targeting different loci
s performed by changing 20 bp of the gRNA, instead of cumber-
omely engineering protein domains as required for comparable .  . .  . . . .  . . .  . . . . .  .  . . . . .  . .  .  .  . . .  . . .  . . . . . . .  .  . . .  .  . . . .  .  .  . . . . .  . . . . . . .  .  .  .  . . .  .  . .  . . . .  .  148
programmable TALEN strategies (Gaj et al., 2013; Kim and Kim,
2014; Weninger et al., 2015b). Due to its outstanding characteristics
compared to other genome modiﬁcation tools in terms of ﬂexibility,
to achieve multiplexing, the ease of retargeting and the potential
to efﬁciently introduce site speciﬁc modiﬁcations, CRISPR/Cas9 is
one of the most promising tools for targeted genome engineering
(Gaj et al., 2013; Weninger et al., 2015b). However implementing
CRISPR/Cas9 in a given organism requires the functional expression
of CAS9 and the gRNA, which is reliant on a set of interdependent
features (Fig. 1) (Jinek et al., 2012; Mali et al., 2013). One frequently
applied strategy is to express the CAS9 gene in the cell. The gene
has to be transcribed, translated and folded correctly in the het-
erologous organism, where genome targeting should be achieved.
In order to target eukaryotic genomes the bacterial protein Cas9
needs to be fused to a nuclear localisation sequence (NLS) to allow
import in the nucleus in eukaryotes. Using different NLSs can have
a pronounced effect on nuclear targeting (Nelson and Silver, 1989;
Weninger et al., 2015a). Furthermore cytotoxic effects of the large,
overexpressed 160 kDa protein need to be minimized. The gRNA
must remain in the nucleus and 5′ or 3′ RNA sequences, which
might be added in the course of its transcription, must not have a
negative inﬂuence on correct localization, folding and functionality.
Cas9 and the gRNA have to assemble in the nucleus and the RNA-
protein complex has to recognize the targeted homologous locus
in the genome in order to introduce a strand break. Unspeciﬁed
off-targeting and toxicity effects caused by overexpression must
not have detrimental or lethal effects on the cells. Hence, efﬁcient
genome targeting can only be achieved, when all single compo-
nents are correctly designed, expressed, produced and assembled
in the host.
In this study, we aimed to develop a CRISPR/Cas9 system that
enables speciﬁc and precise genome engineering in P. pastoris as
a potent alternative to the currently applied genome engineering
strategies.
2. Materials and methods
2.1. Chemicals
Enzymes were obtained from Thermo Fisher Scientiﬁc, Vienna,Carlsbad, CA, US and InvivoGen, France. Other chemicals were pur-
chased from Carl Roth, Karlsruhe, Germany. Oligonucleotides were
ordered from Integrated DNA Technologies, Leuven Belgium, see
Supplementary Table S1 for the sequences.
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Fig. 1. Critical features for CAS9/gRNA expression affecting the genome editing efﬁciency.
Implementing CRISPR/Cas9 in a given organism is reliant on a set of interdependent components. These features include the DNA sequence of CAS9, the type and position of
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red)  and the target DNA for cleavage (yellow). The illustration of the Cas9/gRNA co
.2. Strains and constructs
All strains in this study were based on the P. pastoris wildtype
train CBS 7435 (identical to NRRL Y-11430 and ATCC 76273). The
lasmids used for the expression of the CRISPR/Cas9 constructs
re based on the E.coli/P. pastoris shuttle vector pPpT4 GAP (Gen-
ank accession number: JQ519692, (Näätsaari et al., 2012)). The
utonomously replicating sequence (ARS) PARS1 was  ampliﬁed
rom P. pastoris CBS7435 genomic DNA using the primers AODTT-
ARS1-fw-Gib and pUCORI-PARS1-rv-Gib. The pPpT4 GAP plasmid
as linearized with PstI  and the PARS1 PCR fragment was  inserted
y Gibson assembly, resulting in the plasmid pPpT4 GAP-PARS1.
ll plasmids were sequenced by Sanger sequencing (Microsynth,
ienna, Austria). Maps of key plasmids generated in this study are
rovided in Supplementary File S2.
.2.1. Constructs bearing RNA pol III promoters for gRNA
xpression
A P. pastoris codon optimized CAS9 sequence was  ordered
n ﬁve overlapping synthetic double stranded DNA fragments
gBlocks, Integrated DNA technologies, Cas9-1–Cas9-5) and the
Blocks were combined by overlap extension (OE) PCR (Cas9-
fw/Cas9.5-rv). The Homo sapiens codon optimized CAS9 (HsCAS9)
nd the Streptococcus pyogenes CAS9 (SpCAS9) were ampliﬁed
rom the template vectors p414-TEF1p-Cas9-CYC1t and pMJ806
both obtained from Addgene, Cambridge, MA,  USA) using
rimer pairs spCas9 fw/spCas9-SV40 rv and hsCas9 fw/hsCas9-
V40 rv respectively. Upon performing an EcoRI and NotI digest
f pPpT4 GAP-PARS1 we inserted the CAS9 PCR fragments
mmediately downstream of PGAP by Gibson assembly, yield-
ng pPpT4 GAP-PARS1-hsCas9, pPpT4 GAP-PARS1-spCas9 and
PpT4 GAP-PARS1-ppCas9. The RNA Polymerase III (RNA Pol III)
romoters (see Supplementary Table 3 for sequences) PScSNR52,
ScRPR1, PScSUP4, PPpLYS , PPpMET , PPpSER and PScSCR1 were ampliﬁed
rom S. cerevisiae (Sc) ATCC 204508/S288c and P. pastoris (Pp) CBS
435 genomic DNA (pucori-SNR52-fw-Gib/gRNA-SNR52-rv-Gib,
ucori-RPR1-fw-Gib/gRNA-RPR1-rv-Gib, pucori-pLYS-fw-
ib/gRNA-pLYS-rv-Gib, pucori-pMET-fw-Gib/gRNA-pMET-rv-Gib,
ucori-pSER-fw-Gib/gRNA-pSER-rv-Gib, pucori-SUP4-fw-
ib/gRNA-SUP4-rv-Gib, pucori-SCR1-fw-Gib/gRNA-SCR1-rv-Gib).
he RNA Pol III promoters PSpRPR1, PPaASN and PKlSNR52 were ordered
s gBlocks (SNR52-K-lactis, RPR1-S-pombe, ASN-P-angusta). The
AS9 containing vectors, pPpT4 GAP-PARS1-hsCas9, pPpT4 GAP-oter for the expression of the gRNAs, the introduction of processing elements for
mid are not drawn to scale. Cas9 (blue) shown on the right side includes the gRNA
 was  taken from the RCSB PDB (see acknowledgements).
PARS1-spCas9 and pPpT4 GAP-PARS1-ppCas9, were cut with PciI
and SwaI and the RNA Polymerase III promoter and a gBlock
containing the gRNA and the SUP4 RNA Polymerase III terminator
sequence were added to the vectors by Gibson assembly (ﬁnal
maps in S2).
2.2.2. Constructs bearing RNA pol II promoters for gRNA
expression
Constructs, which contain an RNA polymerase II (RNA Pol II)
promoter for the expression of the gRNA are based on pPpT4 GAP-
PARS1 vector, described above. The GAP promoter was  removed
by SwaI/NotI double digest. Bidirectional RNA Pol II promoters
(a fusion of PGAP/PTEF promoters (Vogl and Glieder 2013; Vogl
et al., 2014), PHTA1/PHTB1 = PHTX1 (Geier et al., 2015), PDAS1/PDAS2
(Vogl and Glieder 2013; Vogl et al., 2014) were ampliﬁed
using the primer pairs pTEF1-rv/pGAP-fw, DAS1TT-pHXT1-
fw/AOXTT-HTX1-rv-Gibson, DAS1-2-fw/AOXTT-DAS1-2-rv. The
DAS1 terminator was  ampliﬁed from P. pastoris gDNA (pUC-
ORI-DAS1TT-Gibson/pHTX1-DAS1TT-Gibson). Vectors were built,
which contain a bidirectional promoter ﬂanked by two  ter-
minators (AOX1TT and DAS1TT) by Gibson assembly, yielding
pPpT4 GAP/TEF-PARS1 and pPpT4 HTX1-PARS1. The plasmids
contain an EcoRI RE-site upstream and a NotI RE-site and down-
stream of the bidirectional promoter. The CAS9-PCR fragment
(EcoRI digest of pPpT4 HTX1-PARS1) and a gBlock, containing
the gRNA, (NotI digest of pPpT4 HTX1-PARS1-Cas9) were con-
secutively cloned into the plasmids by Gibson assembly. The
Gibson-primers used to amplify various CAS9 sequences (PpCAS9,
SpCAS9, HsCAS9: pHTX1-ppCas9-Gibson/DAS1TT-ppCas9-Gibson,
HTX1-spCas9-Gibson/DAS1TT-spCas9-Gibson, HTX1-hsCas9-
Gibson/DAS1TT-hsCas9-Gibson), as well as the gBlocks containing
different gRNA sequences (RZ-GUT1-gRNA1-RZ, RZ-GUT1-gRNA2-
RZ, RZ-GUT1-gRNA3-RZ) are listed in the Supplementary Table
1.
2.2.3. P. pastoris target genes and multiplexing
gRNAs to target the coding sequences of the AOX1, MPP1
(homolog of Hansenula polymorpha (Leão-Helder et al., 2003)),
TRM1 (Sahu et al., 2014), OCH1 (Krainer et al., 2013) and MXR1
(Lin-Cereghino et al., 2006) genes were ordered on gBlocks
(RZ-AOX1-gRNA1-RZ, RZ-AOX1-gRNA2-RZ, RZ-AOX1-gRNA3-RZ,
RZ-MXR1-gRNA1-RZ, RZ-MXR1-gRNA2-RZ, RZ-MXR1-gRNA3-RZ,
RZ-MPP1-gRNA1-RZ, RZ-MPP1-gRNA1-RZ, RZ-MPP1-gRNA3-RZ,
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Z-TRM1-gRNA1-RZ, RZ-TRM1-gRNA2-RZ, RZ-TRM1-gRNA3-RZ,
Z-OCH1-gRNA1-RZ, RZ-OCH1-gRNA2-RZ, RZ-OCH1-gRNA3-RZ).
he pPpT4 pHTX1-PARS1-hsCas9 was linearized using NotI and
he gBlocks were cloned into the vector by Gibsson assembly.
or multiplexing experiments a plasmid bearing HsCas9 and
RNA2 to target GUT1 (pPpT4 pHTX1-hsCas9-GUT1-gRNA2)
as linearized with SwaI. The HHF2 promoter (Vogl et al.,
014) was ampliﬁed using different primer pairs (pAOXsyn-
HHF2-fw-Gibson/HH-AOX1-gRNA1-pHHF2-rv-Gibson,
AOXsyn-pHHF2-fw-Gibson/HH-AOX1-gRNA2-pHHF2-rv-Gibson,
AOXsyn-pHHF2-fw-Gibson/HH-AOX1-gRNA3-pHHF2-rv-
ibson). The resulting PCR fragments had different overhangs
or Gibson assembly. Three gBlocks were ordered bearing either
OX1-gRNA1, AOX1-gRNA2 or AOX1-gRNA3 and the DAS1 termi-
ator. The promoter fragments and the corresponding gBlocks,
ontaining the gRNA and a terminator, were cloned into the vector
ackbone.
.2.4. HR donor cassettes
Roughly 1000 bp regions 5′ upstream and 3′ downstream
f the target gene GUT1 were selected to complement a SwaI
estriction site and ampliﬁed from P. pastoris CBS 7435 genomic
NA with overhangs to a Zeocin marker cassette (containing
ARG4 as in pPpRSFC-HIS plasmids (Vogl et al., 2015), kindly
rovided by Mudassar Ahmad) using the following primers:
UT1: 3UTRGUTF/3UTRGUTR, 5UTRGUTF/5UTRGUTR). The GUT1-
CR fragments, joined by OE-PCR (3UTRGUTF/5UTRGUTR), and the
eocin marker cassette were assembled by Gibson assembly. For
he P. pastoris transformation the plasmids were SwaI-linearized
nd one g DNA was used for the transformation of competent cells.
 second type of donor DNA cassette was generated which contains
000 bp regions 5′ upstream and 3′ downstream of the target gene
irectly fused together. The 5′ upstream and the 3′ downstream
egions of the GUT1 locus were ampliﬁed from P. pastoris genomic
NA (5GUT1 fw/5GUT1 rv, 3GUT1 fw/3GUT1 rv). The PCR frag-
ents were joined by OE-PCR (outer primers 5GUT1 fw/3GUT1 rv)
nd cloned into the pJET1.2 blunt vector (CloneJET PCR Cloning Kit,
isher Scientiﬁc GmbH, Vienna, Austria). For the P. pastoris transfor-
ation the donor cassettes were ampliﬁed from the pJET1.2-GUT1
ector with the outer primers used for the OE-PCR and one g DNA
as added to competent cells.
.3. Transformation and screening
The transformations (100 ng circular plasmid DNA/CRISPR-
as9 plasmids, one g linear plasmid DNA/HR donor cassettes)
ere performed using a condensed electroporation protocol (Lin-
ereghino et al., 2005) and grown for two days on YPD (1% w/v
east extract, 2% w/v peptone and 2% w/v glucose) plates (1.5% agar)
ontaining 100 g/ml Zeocin. For targeting the OCH1 locus, trans-
ormants were cultivated for three days due to slower growth rates.
he transformants were cultivated in 96-deep well plates (Bel-Art
roducts, USA) in 250 l YPD media supplemented with 100 g/ml
eocin for 60 h (as a side note, we also tested cultivation in liq-
id media without Zeocin addition and did not notice differences
n the targeting efﬁciency, suggesting that CRISPR/Cas9 mediated
enome editing takes place in P. pastoris already during the ini-
ial selection on YPD-Zeo agar plates [data not shown]). Methanol
nducible promoters were induced with YPM2 and YPM10 (1% w/v
east extract, 2% w/v peptone and 1% v/v methanol respectively 5%
/v methanol) media for 48 h according to (Weis et al., 2004). Cell
aterial was transferred on a metallic stamp to buffered minimalBM) media plates containing 1.34% YNB, 4 × 10−5% biotin and 0.5%
ethanol, 200 mM potassium phosphate buffer (pH 6.0) and either
% glucose, 1% methanol or 1% glycerol as carbon source. The plates
ere incubated at 28 ◦C for two days. The targeting efﬁciencies ofhnology 235 (2016) 139–149
the single constructs were evaluated by counting normally grow-
ing and growth deﬁcient colonies. Genotypic characterization was
performed by isolating genomic DNA according to the Bust’n’Grab
protocol from (Harju et al., 2004) with minor amendments: Liquid
nitrogen was used in the cell lysis step instead of dry ice-ethanol.
The air tried pellets were resuspended in 50 l distilled H2O and
RNase treatment was not performed. The genomic DNA was  stored
at −20 ◦C. The primers seq-pGUT1-332.308-fwd and 3UTRGUTR
were used for the ampliﬁcation of the GUT1 locus, when a NHEJ-
mediated mutation had been introduced with CRISPR/Cas9 and the
primers GUTout3prR1 and pGUT1fwd were used for the ampliﬁ-
cation of the GUT1 locus, when the cells had been co-transformed
with CRISPR/Cas9 plasmids and donor DNA fragments.
3. Results and discussion
3.1. Implementation of CRISPR/Cas9 in P. pastoris
3.1.1. Using RNA pol III promoters for gRNA expression did not
promote efﬁcient genome editing
Here we  report the ﬁrst CRISPR/Cas9 system for P. pastoris
approaching up to 100% targeting efﬁciency. However, establishing
CRISPR/Cas9 in P. pastoris seemingly required considerable more
efforts than in previous reports in S. cerevisiae (DiCarlo et al., 2013)
and Schizosaccharomyces pombe (Jacobs et al., 2014) and standard
strategies using RNA Pol III promoters were barely successful. In
frame of this work we  varied various parameters of the Cas9/gRNA
expression (Fig. 1) resulting in total of 95 expression plasmids
(Table 1). In detail, especially the optimization of gRNA expression
proved to be critical: Various CRISPR/Cas9 publications report the
functional expression of the gRNA using promoters, which are rec-
ognized by RNA Pol III (Cong et al., 2013; DiCarlo et al., 2013; Fu
et al., 2014; Gilbert et al., 2013; Mali et al., 2013; Ryan et al., 2014).
Naturally, RNA Pol III is transcribing 5S rRNAs, tRNAs and small
non-coding RNAs (Dieci et al., 2007). In contrast to mRNAs of pro-
tein coding genes, which are transcribed by RNA Pol II, transcripts
of RNA Pol III do not contain a 5′-7-methylguanosine cap (5′cap)
and a 3′ polyA tail. The 5′cap is responsible for ribosome recruit-
ment and mRNA translation, whereas the polyA sequence is part
of transcription termination and critical for mRNA stability. Both 5′
cap and polyA tail are important for the export of the mRNA to the
cytoplasm (Lewis and Izaurralde, 1997; Wilusz et al., 2001).
However the nuclear export of gRNAs is undesirable and
sequences added in the course of transcription may hinder gRNA
folding (Jacobs et al., 2014). Thus, RNA pol III promoters were con-
sidered to be better suited for the expression of gRNAs (Cong et al.,
2013; DiCarlo et al., 2013; Mali et al., 2013). In total we tested ten
different heterologous and endogenous RNA polymerase III pro-
moters for the expression of single gRNAs: The SNR52,  RPR1, SCR1
and SUP4 promoters from S. cerevisiae, the P. pastoris endogenous t-
RNA promoters PPpLYS , PPpMET and PPpSER, PPaASN from Pichia angusta
(H. polymorpha), PKlSNR52 from Kluyveromyces lactis and PSpRPR1 from
S. pombe.  As a test locus we  attempted editing the GUT1 gene, which
encodes for a glycerol kinase in P. pastoris. GUT1 defective strains
display a reduced growth phenotype on glycerol as carbon source
compared to the wild type strain (Näätsaari et al., 2012). Hence
mutations in the GUT1 gene can be easily detected by stamping
the cells on glycerol plates (Supplementary Fig. S4). We  designed
three gRNAs to target the GUT1 coding sequence (CDS) 125, 256
and 429 bp from the start codon. The gRNA expression cassette con-
sisted of an RNA Pol III promoter, the 20 bp variable gRNA to target
GUT1, the structural component of the gRNA (stgRNA1) and the
SUP4 3′ ﬂanking terminator sequence (both successfully used for
CRISPR/Cas9 targeting in S. cerevisiae by (DiCarlo et al., 2013)). To
match the P. pastoris codon bias we codon optimized CAS9 (PpCAS9)
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Table  1
Overview of the various features and combinations tested to implement CRISPR/Cas9 in the methylotrophic yeast P. pastoris. GUT1 was selected as a test locus. Mutations in
the  GUT1 locus cause a reduced growth phenotype on glycerol. Transformants were cultivated in 96-DWPs and transferred to minimal media plates. The targeting efﬁciency
was  calculated by comparing normally growing and glycerol defective mutants.
CRISPR/Cas9 constructs Screening
Constructs Promoter
Cas9
CAS9
sequence
Promoter
gRNA
variable
gRNA
structural
gRNA
Ribozyme ﬂanked
gRNA expression
Normal Reduced Mixed Target-ing eff.
1 PGAP PpCAS9 PScSNR52 1 1 – 84 0 0 0.0
2  PGAP PpCAS9 PScSNR52 2 1 – 84 0 0 0.0
3  PGAP PpCAS9 PScSNR52 3 1 – 84 0 0 0.0
4  PGAP PpCAS9 PScSNR52 4 1 – 84 0 0 0.0
5  PGAP PpCAS9 PScSNR52 5 1 – 84 0 0 0.0
6  PGAP PpCAS9 PScRPR1 1 1 – 84 0 0 0.0
7  PGAP PpCAS9 PScRPR1 2 1 – 84 0 0 0.0
8  PGAP PpCAS9 PScRPR1 3 1 – 84 0 0 0.0
9  PGAP PpCAS9 PScSUP4 1 1 – 84 0 0 0.0
10  PGAP PpCAS9 PScSUP4 2 1 – 84 0 0 0.0
11  PGAP PpCAS9 PScSUP4 3 1 – 84 0 0 0.0
12  PGAP PpCAS9 PPpLYS 1 1 – 84 0 0 0.0
13  PGAP PpCAS9 PPpLYS 2 1 – 84 0 0 0.0
14  PGAP PpCAS9 PPpLYS 3 1 – 84 0 0 0.0
15  PGAP PpCAS9 PPpMET 1 1 – 84 0 0 0.0
16  PGAP PpCAS9 PPpMET 2 1 – 84 0 0 0.0
17  PGAP PpCAS9 PPpMET 3 1 – 84 0 0 0.0
18  PGAP PpCAS9 PPpSER 1 1 – 84 0 0 0.0
19  PGAP PpCAS9 PPpSER 2 1 – 84 0 0 0.0
20  PGAP PpCAS9 PPpSER 3 1 – 84 0 0 0.0
21  PGAP PpCAS9 PKlSNR52 1 1 – 84 0 0 0.0
22  PGAP PpCAS9 PKlSNR52 2 1 – 84 0 0 0.0
23  PGAP PpCAS9 PKlSNR52 3 1 – 84 0 0 0.0
24  PGAP PpCAS9 PSpRPR1 1 1 – 84 0 0 0.0
25  PGAP PpCAS9 PSpRPR1 2 1 – 84 0 0 0.0
26  PGAP PpCAS9 PSpRPR1 3 1 – 84 0 0 0.0
27  PGAP PpCAS9 PPaASN 1 1 – 84 0 0 0.0
28  PGAP PpCAS9 PPaASN 2 1 – 84 0 0 0.0
29  PGAP PpCAS9 PPaASN 3 1 – 84 0 0 0.0
30  PGAP PpCAS9 PScSCR1 1 1 – 84 0 0 0.0
31  PGAP PpCAS9 PScSCR1 2 1 – 84 0 0 0.0
32  PGAP PpCAS9 PScSCR1 3 1 – 84 0 0 0.0
33  PGAP HsCAS9 PScSNR52 1 1 – 42 0 0 0.0
34  PGAP HsCAS9 PScSNR52 2 1 – 42 0 0 0.0
35  PGAP HsCAS9 PScSNR52 3 1 – 42 0 0 0.0
36  PGAP HsCAS9 PScRPR1 1 1 – 42 0 0 0.0
37  PGAP HsCAS9 PScRPR1 2 1 – 42 0 0 0.0
38  PGAP HsCAS9 PScRPR1 3 1 – 42 0 0 0.0
39  PGAP HsCAS9 PScSUP4 1 1 – 42 0 0 0.0
40  PGAP HsCAS9 PScSUP4 2 1 – 42 0 0 0.0
41  PGAP HsCAS9 PScSUP4 3 1 – 42 0 0 0.0
42  PGAP HsCAS9 PPpLYS 1 1 – 42 0 0 0.0
43  PGAP HsCAS9 PPpLYS 2 1 – 42 0 0 0.0
44  PGAP HsCAS9 PPpLYS 3 1 – 42 0 0 0.0
45  PGAP HsCAS9 PPpMET 1 1 – 42 0 0 0.0
46  PGAP HsCAS9 PPpMET 2 1 – 42 0 0 0.0
47  PGAP HsCAS9 PPpMET 3 1 – 42 0 0 0.0
48  PGAP HsCAS9 PPpSER 1 1 – 42 0 0 0.0
49  PGAP HsCAS9 PPpSER 2 1 – 42 0 0 0.0
50  PGAP HsCAS9 PPpSER 3 1 – 42 0 0 0.0
51  PGAP SpCAS9 PScSNR52 1 1 – 42 0 0 0.0
52  PGAP SpCAS9 PScSNR52 2 1 – 42 0 0 0.0
53  PGAP SpCAS9 PScSNR52 3 1 – 42 0 0 0.0
54  PGAP SpCAS9 PScRPR1 1 1 – 42 0 0 0.0
55  PGAP SpCAS9 PScRPR1 2 1 – 42 0 0 0.0
56  PGAP SpCAS9 PScRPR1 3 1 – 42 0 0 0.0
57  PGAP SpCAS9 PScSUP4 1 1 – 42 0 0 0.0
58  PGAP SpCAS9 PScSUP4 2 1 – 42 0 0 0.0
59  PGAP SpCAS9 PScSUP4 3 1 – 42 0 0 0.0
60  PGAP SpCAS9 PPpLYS 1 1 – 42 0 0 0.0
61  PGAP SpCAS9 PPpLYS 2 1 – 42 0 0 0.0
62  PGAP SpCAS9 PPpLYS 3 1 – 42 0 0 0.0
63  PGAP SpCAS9 PPpMET 1 1 – 42 0 0 0.0
64  PGAP SpCAS9 PPpMET 2 1 – 42 0 0 0.0
65  PGAP SpCAS9 PPpMET 3 1 – 42 0 0 0.0
66  PGAP SpCAS9 PPpSER 1 1 – 42 0 0 0.0
67  PGAP SpCAS9 PPpSER 2 1 – 42 0 0 0.0
68  PGAP SpCAS9 PPpSER 3 1 – 42 0 0 0.0
69  PGAP HsCAS9 PPpSER 1 2 – 84 0 0 0.0
70  PGAP HsCAS9 PPpSER 2 2 – 84 0 0 0.0
71  PGAP HsCAS9 PPpSER 3 2 – 17 26 39 31.7
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Table 1 (Continued)
CRISPR/Cas9 constructs Screening
Constructs Promoter
Cas9
CAS9
sequence
Promoter
gRNA
variable
gRNA
structural
gRNA
Ribozyme ﬂanked
gRNA expression
Normal Reduced Mixed Target-ing eff.
72 PHTA HsCAS9 PPpSER 1 1 – 84 0 0 0.0
73  PHTA HsCAS9 PPpSER 2 1 – 83 0 0 0.0
74  PHTA HsCAS9 PPpSER 3 1 – 84 0 0 0.0
75  PHTA HsCAS9 PPpSER 1 2 – 84 0 0 0.0
76  PHTA HsCAS9 PPpSER 2 2 – 82 0 1 0.0
77  PHTA HsCAS9 PPpSER 3 2 – 33 4 34 5.6
78  PGAP HsCAS9 PTEF 1 2 HH and HDV 15 68 1 81.0
79  PGAP HsCAS9 PTEF 2 2 HH and HDV 16 65 2 78.3
80  PGAP HsCAS9 PTEF 3 2 HH and HDV 11 73 0 86.9
81  PHTA HsCAS9 PHTB 1 2 HH and HDV 11 72 0 86.7
82  PHTA HsCAS9 PHTB 2 2 HH and HDV 5 79 0 94.0
83  PHTA HsCAS9 PHTB 3 2 HH and HDV 14 70 0 83.3
84  PHTA HsCAS9 PHTB none none HH and HDV 84 0 0 0.0
85  PHTA SpCAS9 PHTB 1 2 HH and HDV 84 0 0 0.0
86  PHTA SpCAS9 PHTB 2 2 HH and HDV 82 2 0 2.4
87  PHTA SpCAS9 PHTB 3 2 HH and HDV 84 0 0 0.0
88  PHTA SpCAS9 PHTB none none HH and HDV 84 0 0 0.0
89  PHTA PpCAS9 PHTB 1 2 HH and HDV 42 0 0 0.0
90  PHTA PpCAS9 PHTB 2 2 HH and HDV 41 1 0 2.4
91  PHTA PpCAS9 PHTB 3 2 HH and HDV 39 2 0 4.9
92  PHTA PpCAS9 PHTB none none HH and HDV 84 0 0 0.0
93  PDAS1 HsCAS9 PDAS2 1 2 HH and HDV 84 0 0 0.0
94  PDAS1 HsCAS9 PDAS2 2 2 HH and HDV 84 0 0 0.0
95  PDAS1 HsCAS9 PDAS2 3 2 HH and HDV 84 0 0 0.0
Fig. 2. High efﬁciency implementation of CAS9 and gRNA expression in P. pastoris. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the  web  version of this article.)
(A) Design of CRISPR/Cas9 constructs for P. pastoris. Plasmids 1–77 (Table 1) contained a CAS9 and a gRNA expression cassette, where gRNA expression is driven by an RNA
Pol  III promoter. Extraneous sequences might be added in the course of the transcription and affect the gRNA functionality. Reﬁned plasmids (Table 1, #78–95) contain a
bidirectional RNA Pol II promoter, which directs the expression of CAS9 in reverse orientation and the gRNA ﬂanked by the HH and HDV ribozymes in forward orientation.
Upon  transcription the ribozymes fold and release the mature gRNA. A six bp sequence of the HH ribozyme has to be changed according to the variable sequence of the gRNA.
The  vector parts are not drawn to scale. (B) Targeting efﬁciencies are strongly affected by the codon optimization of CAS9 (striped bars). P. pastoris cells were transformed
with  constructs bearing a ribozyme ﬂanked gRNA (targeting the GUT1 locus) and various CAS9 DNA sequences under the bidirectional promoter PHTX1 (Table 1, #81–92). The
CAS9  DNA sequence expressed upon P. pastoris transformation also inﬂuences the amount of CFUs (colony forming units) obtained (blue, ﬁlled bars). Using SpCAS9 > 20,000
transformants and partly cell lawn were obtained, indicating that the nuclease is barley active having no detrimental effects on cell growth. Mean values and standard
d SPR/C
g  plasm
w ng.
a
G
o
S
C
teviations of biological triplicates are shown. (C) Genotypic characterization of CRI
rowth, 36 showing normal growth) from three independent transformations with
as  isolated and sequences of the GUT1 locus were determined by Sanger sequenci
nd additionally tested the streptococcal CAS9 sequence (SpCAS9,
enBank: AAK33936.1) (Jinek et al., 2012) as well as a human codon
ptimized variant (HsCAS9), which was successfully employed in
. cerevisiae (DiCarlo et al., 2013). The different codon optimized
AS9 genes were placed under the control of the strong constitu-
ive GAP promoter (Vogl and Glieder, 2013; Waterham et al., 1997)as9 modiﬁed transformants. Genomic DNA of 106 transformants (70 showing slow
ids bearing HsCAS9 and ribozyme ﬂanked gRNAs to target GUT1 (Table 1, #81–83)
(Fig. 2A). The SV40 NLS, which was already shown to be functional
in P. pastoris for the import of a bacteriophage polymerase (Hobl
et al., 2013) and a GFP reporter protein (Weninger et al., 2015a), was
C-terminally fused to CAS9 for nuclear targeting. The translocation
of a Cas9-eGFP fusion protein to the nucleus was  observed under
the microscope (Supplementary Fig. S5). The gRNA and the CAS9
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Fig. 3. A ribozyme based strategy for improved gRNA vector design as extraneous
RNA sequences inﬂuence the gRNA targeting efﬁciency.
P.  pastoris cells were transformed with CRISPR/Cas9 plasmids containing HsCAS9
and the respective gRNAs targeting GUT1. The gRNA expression cassettes contained
the identical 3′ HDV ribozyme, but the 5′ termini were varied. (A) Clean-cut/scarless
HH ribozyme cleavage design to avoid leaving additional sequences on the gRNA.
A  6 bp sequence of the HH ribozyme has to be adapted to each gRNA. (B) Omitting
the HH ribozyme leaving the 5′UTR of the promoter as part of the gRNA. (C) Design
of  the HH ribozyme with a linker sequence attached to the gRNA removing the
HH  ribozyme, but leaving the linker as part of the gRNA. Changing the HH variableA. Weninger et al. / Journal of 
xpression cassettes were cloned into episomal plasmids contain-
ng an autonomously replicating sequence (PARS1, (Higgins and
regg, 1998)) and transformed into P. pastoris. This ARS allows plas-
id  curing by simply growing the strains on non-selective media,
hich enabled eventually selection marker free knockout strain
eneration (see Supplementary Fig. S6).
With 65 different combinations of the described elements (plas-
ids 1–65, Table 1), no transformants with growth deﬁciencies
n glycerol plates were identiﬁed, indicating no functional Cas9
ediated genome editing. Changing PGAP for the expression of CAS9
o a differently regulated promoter (monodirectional sides of the
idirectional promoter PHTX1 (Vogl et al., 2014), named PHTA1 and
HTB1, Vogl. et al. manuscript in preparation) also did not result in
lycerol defective transformants. However, changing the structural
RNA component (stgRNA2 used by (Jinek et al., 2012) in vitro)
ielded 31.7% targeting efﬁciency for the GUT1 locus, when PGAP
as used for the expression of HsCAS9 and gRNA3 was placed under
he endogenous SER RNA Pol III promoter (Fig. 2A, Table 1). When
he promoter PHTA1 was used for the expression of HsCAS9, the
argeting efﬁciency decreased to 5.6%. With both functional combi-
ations (PGAP-HsCAS9-AOX1TT/PSER-gRNA3-stgRNA2-SUP4TT and
HTA1-HsCAS9-AOX1TT/PSER-gRNA3-stgRNA2-SUP4TT) also a high
umber of mixed populations was obtained (>30%, see S4). Mixed
opulations hamper screening for correct CRISPR/Cas9 mutants,
specially when no visible phenotype is produced. Changing the
ariable gRNA sequence (gRNA 1 or gRNA2 instead of gRNA3), or
he CAS9 DNA sequence to SpCAS9 or PpCAS9 did not yield any GUT1
efective transformants.
.1.2. A combination of RNA pol II promoters and ribozymes for
RNA expression enabled efﬁcient CRISPR/Cas9 mediated genome
diting
Subsequently, to omit the challenging RNA Pol III promoter
ased gRNA expression, a different approach was performed, where
 ribozyme-ﬂanked gRNA was expressed by an RNA Pol II promoter
Fig. 2A) as previously demonstrated in yeast (Gao and Zhao, 2014;
acobs et al., 2014). Ribozymes are self-splicing RNA elements and
an be used to remove 5′ and 3′ sequences, which are added in
he course of the transcription, from gRNAs (Gao and Zhao, 2014;
yan et al., 2014). We  tested the 5′ cleaving hammerhead (HH)
ibozyme (Pley et al., 1994) in combination with 3′ cleaving hepati-
is delta virus (HDV) ribozyme (Ferre-D’Amare et al., 1998) for the
xpression of gRNA1, gRNA2 and gRNA3 to delete GUT1. Targeting
fﬁciencies of 78–87% were obtained, when PTEF1 (the promoter of
he translation elongation factor 1 alpha (Vogl and Glieder, 2013))
as used for the expression of the gRNA1, gRNA2 or gRNA3 and
GAP for the expression of HsCas9. Slightly higher targeting rates
87%–94%) could be obtained, when the P. pastoris natural bidi-
ectional PHTX1 promoter was used for the simple co-expression
f HsCAS9 and the ribozyme ﬂanked gRNAs. Methanol-inducible
xpression of the HsCAS9 (PDAS2 side of bidirectional PDAS1,2 pro-
oter (Vogl and Glieder, 2013)) and ribozyme ﬂanked gRNAs (PDAS1
ide) was not successful (data not shown).
.1.3. CAS9 codon bias affects transformation rate suggesting
oxic effects
Constructs bearing either SpCAS9 or PpCAS9 under control of
HTX1 and an RNA Pol II promoter for the expression of ribozyme
anked gRNAs yielded only a small number of glycerol defective
utants (Fig. 2B). Hence we infer that codon bias can strongly
ffect Cas9 functionality in a given host. The transformation rates
lso differed strongly depending on the CAS9 sequence expressed.
pproximately 5000 colony forming units (CFUs)/g DNA were
btained after P. pastoris transformation with plasmids encoding
or HsCas9 and a gRNA, whereas only about 500CFUs/g  DNA were
btained for PpCAS9-expressing plasmids. When transforming thesequence according to the gRNA as in (A) is not required. Mean values and standard
deviations of biological triplicates are shown (as in Table 1 and Fig. 2 the GUT1 locus
was  targeted).
cells with a plasmid bearing SpCAS9, more than 20000CFUs/g DNA
were obtained (Fig. 2B). PpCAS9 expression appeared to have a
toxic effect on the cells indicated by the low transformation rate,
whereas SpCAS9 seems to be not to be functionally produced, since
these transformants were still growing on glycerol as sole carbon
source. The use of PpCAS9 was even detrimental when no gRNA was
co-expressed.
To validate that the observed phenotype is caused by speciﬁc
gRNA guided cleavage of the Cas9-gRNA complex we sequenced
glycerol defective and normally growing transformants. Inter-
estingly, in P. pastoris in > 90% of all mutation events (64/70
transformants sequenced), a single bp upstream of the Cas9 cleav-
age position was  deleted independently from the gRNA used
(Fig. 2C), whereas in S. cerevisiae deletions and insertions (indels) of
different lengths have been reported (DiCarlo et al., 2013). Appar-
ently the NHEJ mechanism in P. pastoris is somewhat different from
S. cerevisiae. The majority of the normally growing transformants
(66.7%, 24/36 transformants sequenced) did not contain a mutation
in the GUT1 locus. Other normally growing transformants contained
a three bp deletion (resulting in the deletion of one amino acid),
which apparently did not destroy the protein functionality (Fig. 2C).
3.2. A ribozyme based strategy for improved vector design
The ribozyme strategy for gRNA expression, where the gRNA is
ﬂanked by 5′ and 3′ self-processing RNA elements to obtain cor-
rectly processed gRNAs, showed by far the best results regarding
targeting efﬁciencies for our P. pastoris CRISPR/Cas9 expression vec-
tors. Upon transcription both ribozymes induce sequence speciﬁc
cleavage of a phosphodiester bond (Doudna and Cech, 2002) result-
ing in a mature gRNA. However this strategy required the alteration
of a short six bp sequence of the 5′ cleaving HH ribozyme each time
a new gRNA sequence was used (Fig. 3A). This is inconvenient for
plasmid design, because not only the variable gRNA part needs to
be changed, but also the corresponding part of the HH ribozyme
(Fig. 3A). In order to simplify the design of the gRNA expression
cassette we omitted the HH sequence by directly fusing the pro-
moter PHTX1 to the gRNA (Fig. 3B). Similar targeting rates were
obtained with the ribozyme ﬂanked GUT1-gRNA1 (90 ± 4%) and
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Fig. 4. The CRISPR/Cas9 system allows high efﬁciency targeting of various genes (A)
and is suitable for multiplexing (B, C) in P. pastoris.
(A) P. pastoris cells were transformed with plasmids (based on designs #81–83,
Table 1, maps see S2) bearing HsCAS9 and ribozyme ﬂanked gRNAs under the control
of  PHTX1. Three gRNAs per construct were designed to target each gene. Transfor-
mants, grown in 96-DWPs, were transferred with a metallic stamp to minimal media
agar plates with either glucose (BMD1) or methanol (BMM1) as carbon source and
growth defects were denoted. For OCH1, we visually screened for growth defects
and  altered cell morphology reported by (Krainer et al., 2013). Mean values and
standard deviations of biological triplicates are shown. (B) Cells were transformed
with plasmids (based on design #82, Table 1) bearing HsCAS9, GUT1-gRNA2 and a
gRNA to target AOX1 (gRNA1, gRNA2 or gRNA3) and stamped onto BMD1, BMM1 and
glycerol (BMG1) containing agar plates Depending on the gRNA combination used
multiplexing efﬁciencies up to 69% were obtained. Mean values and standard devi-
ations of biological triplicates are shown. (C) Representative experimental data of
the phenotypic characterization of the experiments in (B) are shown (CRISPR/Cas9
plasmid bearing the gRNAs AOX1-gRNA2 and GUT1-gRNA2). As controls the P. pas-46 A. Weninger et al. / Journal of 
he construct, where the HH ribozyme was abandoned (89 ± 2%)
Fig. 3B). However the targeting efﬁciencies deteriorated with
UT1-gRNA2 (2 ± 3%) and GUT1-gRNA3 (58 ± 20%) compared to
onstructs expressing the ribozyme ﬂanked gRNAs (95 ± 1 and
4 ± 1% respectively). The transcription start of many RNA Pol II
romoters is not in direct proximity to the translational start site,
ut the average length of 5′ untranslated regions (UTRs) is 50 bp in
east (Nagalakshmi et al., 2008). By abandoning the HH ribozyme
he 5′UTR, which is essential for translation initiation, extends the
RNA. The 5′UTR of RNA Pol II transcribed genes contains also a
′cap, which is involved in the translocation of the mRNA to the
ytoplasm and might lead to a decrease in nuclear gRNA levels.
dditionally the 5′UTR might base pair with the gRNA and inhibit
ts overall functionality. Although we were able to achieve efﬁ-
ient CRISPR/Cas9 targeting with two out of three gRNAs, when
he 5′ UTR of the PHTX1 remains attached to the gRNA, changing the
romoter for gRNA expression might further diminish gRNA func-
ionality. In order to abolish the promoter/5′UTR based inﬂuence on
he gRNA we designed a six bp linker consisting of the random bases
TCAGAT” and located the linker upstream of the gRNA sequence
Fig. 3C). Upon transcription the HH ribozyme base pairs with the
inker and cleaves the RNA, removing the 5′UTR sequence and leav-
ng the six bp linker attached to the gRNA. The targeting efﬁciencies
sing GUT1-gRNA1 (94 ± 2%) and GUT1-gRNA3 (89 ± 7%) were sim-
lar compared to constructs expressing the ribozyme ﬂanked gRNAs
90 ± 4 and 84 ± 1% respectively). When expressing gRNA2 the tar-
eting rate declined to 5 ± 2%, which is marginally higher to the
onstruct, where the HH ribozyme was omitted (Fig. 3C vs. Fig. 3B).
his experiment further demonstrated that the functionality of the
RNA is strongly dependent on additional sequences, which might
e added in the course of the transcription. In some cases even
hort oligos of six bp can completely impede efﬁcient gene target-
ng, whereas some gRNAs remain functional even if the 5′UTR of
he promoter remains attached. Although all gRNAs tested for the
UT1 locus enabled highly efﬁcient gene targeting, when they were
anked by a 5′ and a 3′ cleaving ribozyme, this strategy requires
dapting the HH ribozyme according to the gRNA used (Gao and
hao, 2014). Here integrating a linker to basepair with the HH
ibozyme offers a practical alternative for fast and simpliﬁed vector
esign, keeping in mind that the functionality of some gRNAs might
e negatively affected. For optimal functionality of the gRNAs dual
ibozyme cleavage resulting in full removal of additional sequences
o far remains the most reliable method in P. pastoris.
.3. Efﬁcient gene targeting and multiplex genome editing
After having established a high efﬁciency CRISPR/Cas9 system
n P. pastoris, we aimed to validate the general applicability by
argeting other genes and using simultaneously multiple gRNAs
multiplexing). For these experiments, we used the most efﬁcient
onstruct obtained from the combinatorial expression optimiza-
ion process, which contains the promoter PHTX1 for the expression
f HsCAS9 (Table 1: #84, S2: pPpT4 pHTX1-PARS1-HsCas9). The
ibozyme ﬂanked gRNAs (HH-gRNA-HDV) to target various genes
ere ordered as synthetic double stranded DNA fragments and
dded to the plasmid by Gibson assembly (see materials and
ethods). We  targeted ﬁve genes located on different chromo-
omes in addition to GUT1, namely AOX1, TRM1 (Sahu et al., 2014),
PP1 (homolog of P. angusta (Leão-Helder et al., 2003)), MXR1
Lin-Cereghino et al., 2006) and OCH1 (Krainer et al., 2013; Nett
nd Gerngross, 2003) (Fig. 4A). AOX1, MXR1, TRM1 and MPP1 are
nvolved in the methanol metabolism in P. pastoris, either with key
nzymatic or activating transcription regulatory function. The func-
ion of MPP1 in P. pastoris has so far not been investigated, but the
omolog in P. angusta is involved in methanol dependent gene reg-
lation (Leão-Helder et al., 2003). Knockouts of these genes could betoris wildtype strain (WT), mutS (AOX1) and a GUT1 strain were used (Näätsaari
et  al., 2012).
easily screened by stamping the on agar plates containing methanol
as sole carbon source and assaying growth. OCH1 encodes for a -
1,6-mannosyltransferase and knocking out OCH1 generates more
homogenous glycoproteins, but impairs the cell wall integrity and
cell growth (Krainer et al., 2013). This locus was selected, because it
had proven to be difﬁcult for targeting in previous studies (Krainer
et al., 2013; Nett and Gerngross, 2003). Three gRNAs were designed
for each locus. Upon transformation random clones were screened
as described in the materials and methods section. In case a NHEJ
mutation had been introduced in the target loci, a retarded growth
phenotype could be observed. The mutation frequencies of TRM1,
AOX1 and MPP1 approach 100% for the best gRNA. However, when
some gRNAs were used, hardly any transformants with reduced
growth phenotype were obtained (i.e. TRM1-gRNA2, MXR1-gRNA1,
MXR1-gRNA3, OCH1-gRNA1 and OCH1-gRNA2). The gRNAs might
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ot be incorporated correctly into Cas9 due to sequence speciﬁc
NA-folding Also the target sequences might be inaccessible to
he nuclease due to the chromatin status. This notion may  explain
hy two out of three gRNAs designed to target MXR1 and OCH1
ere barely functional and that average targeting frequencies of
nly 43 ± 14% with MXR1-gRNA2 and of only 51 ± 11% with OCH1-
RNA3 were obtained. However in case of the difﬁcult OCH1 locus,
he efﬁciency was still ∼50 times higher than in previous efforts
pplying conventional knockout cassettes (Nett and Gerngross,
003). These results suggest that it is beneﬁcial to test more than
ne gRNA, when trying to introduce mutations in a speciﬁc locus.
ome gRNAs might not be functional at all and screening a larger
umber of transformants will not increase the probability to iden-
ify a correct CRISPR/Cas9 mutant.
We  also simultaneously mutated different genomic loci by
xpressing two gRNAs on a CRISPR/Cas9 plasmid to demon-
trate multiplexing (Cong et al., 2013). Both targeted loci, GUT1
nd AOX1, were successfully deleted in up to 69 ± 13% of the
ransformants using the combination GUT1-gRNA3/AOX1-gRNA3
Fig. 4B and C). Although the targeting efﬁciencies for AOX1-
RNA1 and GUT1-gRNA3 were >90%, when a single gRNA was
xpressed, the mutation efﬁciency decreased when the gRNAs were
imultaneously expressed. The multiplexing rates obviously differ
epending on the gRNA combination. An approximately 10-fold
eduction of CFUs was observed compared to transformations using
RISPR/Cas9 plasmids carrying a single gRNA. This negative effect
as possibly caused by toxic off-targeting which conceivably mul-
iplied with the increased number of gRNAs. Nevertheless, hardly
ny transformant contained a mutation in only one of the target
oci, indicating that CRISPR/Cas9 can be used to modify several
enomic loci in P. pastoris at the same time.
.4. CRISPR/Cas9 and donor DNA co-transformations
The integration of a homologous donor DNA cassette at a
enomic locus requires the HR-repair machinery of the cell and
n endogenous or exogenous homologous donor sequence. Offer-
ng a donor DNA allows also to completely delete an ORF to replace
t with a different sequence or to insert sequences coding e.g. for a
ag. The speciﬁc integration rate can be increased by using site spe-
iﬁc nucleases introducing a strand break at the desired integration
ocus (Caldecott, 2008; Rouet et al., 1994; Smih et al., 1995; Storici
t al., 2003). Without a donor DNA, such double stranded breaks can
nly be repaired by the NHEJ mechanism, which may  result in short
ndels in the ORF (Barnes, 2001), as demonstrated in Fig. 2 to Fig. 4
or P. pastoris. In order to show potential effects of CRISPR/Cas9
ntroduced strand breaks on the HR-mediated integration rate
f donor cassettes, we performed co-transformation experiments
sing various donor cassettes of different sizes (Fig. 5A). One con-
isted of a Zeocin marker cassette ﬂanked by homologous arms
3.8 kbp) and the other consisted of two homologous arms directly
used together (2 kbp). The cassette without a resistance marker
ould allow the complete removal of ORFs without leaving a resis-
ance marker or other scars in the genome. We  expected that a
o-transformation of cells with the CRISPR/Cas9 plasmid and a
onor cassette would increase homologous recombination rates
ue to the site speciﬁc strand break. However, in most cases (Fig. 5B
nd C) the homologous donor was only integrated at low levels
imilar to the control, where solely the donor cassette (with Zeocin
arker) had been transformed (2.4%). The number of transformants
donor cassette + CRISPR/Cas9 plasmid) was similar to the transfor-
ations, where the cells were only transformed with a CRISPR/Cas9
lasmid (approximately 5000CFUs per transformation) and also the
ize of the donor fragment did not have a pronounced effect on
he integration efﬁciency. Yet, when cells were transformed with
 CRISPR/Cas9 plasmid bearing gRNA1 and the donor cassette con-hnology 235 (2016) 139–149 147
taining the Zeocin cassette, an approximately 10-fold increase in
the integration efﬁciency of the donor DNA was observed. These
results suggest that, although NHEJ remained the preferred path-
way for repair in our experiments, donor cassette supplementation
has the potential to facilitate genome engineering in P. pastoris.
Nonetheless, developing a reliable, generally applicable strategy
for facilitated integration of donor fragments using CRISPR/Cas9,
which can be adapted to arbitrary target genes and donor cassettes,
will require further optimizations. Therefore a Cas9 nickase vari-
ant (Jinek et al., 2012; Shen et al., 2014) might be used. Nickases
introduce single strand breaks, which are used as a starting point
of HR-mediated DNA repair (Gasiunas and Siksnys, 2013). Thus,
the frequency of harmful ds breaks and of (unwanted) NHEJ-repair
mediated mutations might be reduced.
4. Conclusion
There appears to be a narrow window of optimal conditions
required for efﬁcient CRISPRS/Cas9 function in P. pastoris, giv-
ing a possible explanation why so far no CRISPR/Cas9 system
has been reported for this widely used methylotrophic yeast.
We systematically tested over 90 constructs containing different
codon optimized DNA sequences of CAS9, various gRNA sequences,
several RNA Pol III and RNA Pol II promoters (in combination
with ribozymes) for the expression of the gRNAs, different RNA
Pol II promoters for the expression of CAS9 and gRNAs. Surpris-
ingly, changing a single feature (e.g. the CAS9 DNA sequence to
match P. pastoris codon bias) could completely abolish CRISPR/Cas9
functionality. Only ∼6% (6/95) of our tested constructs medi-
ated efﬁcient CRISPR/Cas9 targeting, namely those bearing RNA
Pol II promoters, ribozymes and a human codon optimized Cas9
sequence. Taking a few representative examples we have demon-
strated the wide applicability of our CRISPR/Cas9 system for the
knockout of several genomic loci. For most loci we  observed
targeting efﬁciencies close to 100%. Multiplexing was  demon-
strated by using dual cutting guide RNAs and the system was also
characterized in respect to the integration of homologous donor
cassettes. Due to the efﬁcient marker free and precise alterations
in the genome now also speciﬁc phenotypes generated by reading
frame interruption/removal can be studied. This approach provides
major advantages compared to classic knock-out, knock-in strate-
gies where overlapping promoter/terminator and other regulatory
sequences might be concerned as well. Researchers can now beneﬁt
from a tailored CRISPR/Cas9 system for P. pastoris, which will help to
overcome current obstacles in strain optimization and to address
future needs in the ﬁelds of synthetic biology, biotechnology as
well as metabolic pathway engineering. These results provide a
powerful platform for genome engineering for the P. pastoris com-
munity and may  serve as a basis to implement the whole range of
CRISPR-based tools for genome engineering (CRISPR-TF, RFNs, MCR
technology etc.) in P. pastoris (Gantz and Bier, 2015; Gilbert et al.,
2013; Shen et al., 2014; Tsai et al., 2014). We  provide hereby to the
best of our knowledge the most comprehensive study available for
implementing CRISPR/Cas9 in a single eukaryotic host organism.
Our results suggest that de novo establishment of high efﬁciency
CRISR/Cas9 mediated genome engineering can be a lengthy, cum-
bersome process in certain organisms. Hence the combinatorial
optimization approach demonstrated here, may also act as a useful
guideline for the setup of CRISPR/Cas9 in other organisms.Author’s contributions
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